BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27698388)

  • 1. The variances of Sp1 and NF-κB elements correlate with the greater capacity of Chinese HIV-1 B'-LTR for driving gene expression.
    Qu D; Li C; Sang F; Li Q; Jiang ZQ; Xu LR; Guo HJ; Zhang C; Wang JH
    Sci Rep; 2016 Oct; 6():34532. PubMed ID: 27698388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter.
    Verma A; Rajagopalan P; Lotke R; Varghese R; Selvam D; Kundu TK; Ranga U
    J Virol; 2016 Aug; 90(16):7046-7065. PubMed ID: 27194770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
    Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
    Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sp1 and related factors fail to interact with the NF-kappaB-proximal G/C box in the LTR of a replication competent, brain-derived strain of HIV-1 (YU-2).
    Millhouse S; Krebs FC; Yao J; McAllister JJ; Conner J; Ross H; Wigdahl B
    J Neurovirol; 1998 Jun; 4(3):312-23. PubMed ID: 9639074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements.
    Desai-Yajnik V; Samuels HH
    Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of HIV-1 gene expression by NF-IL6.
    Tesmer VM; Bina M
    J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF10 inhibits HIV-1 LTR activity through interaction with NF-κB and Sp1 binding motifs.
    Nishitsuji H; Sawada L; Sugiyama R; Takaku H
    FEBS Lett; 2015 Jul; 589(15):2019-25. PubMed ID: 26096782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling.
    Wang H; Liu Y; Huan C; Yang J; Li Z; Zheng B; Wang Y; Zhang W
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1.
    Naghavi MH; Schwartz S; Sönnerborg A; Vahlne A
    AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1293-303. PubMed ID: 10505678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
    Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
    Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Transcriptional Strength of HIV-1 Subtype C Minimizes Gene Expression Noise and Confers Stability to the Viral Latent State.
    Pal S; Jaiswal V; Nala N; Ranga U
    J Virol; 2023 Jan; 97(1):e0137622. PubMed ID: 36533949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
    Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ
    EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human GM-CSF induces HIV-1 LTR by multiple signalling pathways.
    Watanabe S; Murakami T; Nakamura T; Morimoto C; Arai K
    Biochimie; 2002 Jul; 84(7):633-42. PubMed ID: 12453635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types.
    Ross EK; Buckler-White AJ; Rabson AB; Englund G; Martin MA
    J Virol; 1991 Aug; 65(8):4350-8. PubMed ID: 2072454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
    Schafer SL; Hiscott J; Pitha PM
    Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
    Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
    Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappa B binding to the HIV-1 LTR in kidney: implications for HIV-associated nephropathy.
    Bruggeman LA; Adler SH; Klotman PE
    Kidney Int; 2001 Jun; 59(6):2174-81. PubMed ID: 11380819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.